NIVNow™

NIVNow™

NIVNow™

NIVnow™

Rotech's Non-Invasive Ventilation Program

Non-invasive ventilation (NIV) is the gold standard of care to treat COPD exacerbations in certain patients. Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality worldwide. Patients with COPD face significant physiological changes that severely compromise their respiratory systems. COPD symptoms can progressively compromise a patient’s quality of life, affecting their ability to manage day-to-day and physical activities and impairing sleep quality.

Medicare data shows us that hospitals readmit an alarming 22% of COPD patients within 30 days of discharge.

COPD also places a significant economic burden on healthcare systems, with an estimated cost of nearly $50 billion a year1. It is one of the leading causes of hospitalization for adults in the United States. Rotech’s NIVnow program gives patients the resources they need to manage their non-invasive ventilation treatment successfully.

With NIVnow, your patients can make positive changes in their quality of life, and they can do it now!

NIV can improve gas exchange, increase sleep duration, and relieve other symptoms over time to improve patients’ quality of life. Research supports a multifaceted intervention approach, including RT-led respiratory care, medication reconciliation, appropriate oxygen therapy initiation, and patient education – leading to a significant reduction in hospital readmission.2

One study found a 97% decrease in hospital readmittance rates for patients treated with NIV3. Another showed improvements in health-related quality of life, mood, dyspnea, gas exchange, exercise tolerance and lung function decline, with benefits increasing further with time.4

Our support center staff of specially-trained Ventilator Case Managers provides patients with direct customer support 24/7, ensuring that patients receive the ongoing support needed for treatment success. Rotech Ventilator Case Managers work directly with Respiratory Clinicians to help our patients stay compliant and get the most out of their NIV therapy.

NIVnow™ services include:

To learn how NIVnow™ can help improve your patient’s care, contact us today.

SOURCES

  1. https://www.cdc.gov/copd/infographics/copd-costs.html
  2. Coughlin S, Liang WE, Parthasarathy S. Retrospective Assessment of Home Ventilation to Reduce Rehospitalization in Chronic Obstructive Pulmonary Disease. J Clin Sleep Med. 2015 Jun 15;11(6):663-70. doi: 10.5664/jcsm.4780. PMID: 25766720; PMCID: PMC4442227
  3. Coughlin S, Liang WE, Parthasarathy S. Retrospective Assessment of Home Ventilation to Reduce Rehospitalization in Chronic Obstructive Pulmonary Disease. J Clin Sleep Med. 2015 Jun 15;11(6):663-70. doi: 10.5664/jcsm.4780. PMID: 25766720; PMCID: PMC4442227
  4. Duiverman ML, Wempe JB, Bladder G, Vonk JM, Zijlstra JG, Kerstjens HA, Wijkstra PJ. Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial. Respir Res. 2011 Aug 23;12(1):112. doi: 10.1186/1465-9921-12-112. PMID: 21861914; PMCID: PMC3182911.